2008: Late Breaking Posters

Late Breaking Posters

Monday, October 27, 2008

L1

Efficacy and Safety of Canakinumab (ACZ885), a Fully Human Anti-interleukin-1β Antibody, in Cryopyrin Associated Periodic Fever Syndrome: Results of a Multicenter, Randomized, Double-blind, Phase III Study

L2

Transdermal Delivery Of hPTH (1-34) (zp-pth) is Effective in Increasing Bone Mineral Density of the Lumbar Spine and Hip in Postmenopausal Women with Osteoporosis

L3

Early Effects of Denosumab in Postmenopausal Women With Low Bone Mineral Density Previously Treated with Alendronate

L4

Stopping TNF-blockade Therapy in Early RA: Predictors of Sustained Remission

L5

From No Increase to Doubled Risk After Ten Years: Morbidity and Mortality from Myocardial Infarction in Newly Diagnosed Rheumatoid Arthritis

L6

Type 1 Interferon Pathway Activation Predicts Flares of Disease Activity in SLE

L7

Beneficial Relationship of Serum Urate (sUA) Reduction and Estimated Glomerular Filtration Rate (eGFR) Improvement/Maintenance in Hyperuricemic Gout Subjects Treated for up to 5.5 Years with Febuxostat (FEB)

L8

Limited Efficacy of Glucocorticoids in Very Early Arthritis - Results of the Stop Arthritis Very Early (SAVE) Trial, an International Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial

L9

Treatment of Osteoarthritis (OA) With Continuous vs Intermittent Celecoxib

L10

Long-circulating Liposomal Prednisolone versus Pulse Intramuscular Methylprednisolone in Patients with Active Rheumatoid Arthritis

See more of: Late Breaking Abstract Poster Sessions

<< Previous Session Level | Next Session Level >>